A recent study published in the Journal of Clinical and Translational Hepatology reveals significant connections between the gut microbiome, bile acids, and the development of parenteral nutrition-associated cholestasis (PNAC) in premature infants. This research highlights how variations in the gut microbiome and fecal bile acid content may play a crucial role in the susceptibility of preterm infants to PNAC.
The study involved 22 preterm infants who were monitored in a neonatal intensive care unit (NICU). Researchers collected serial bilirubin measurements and fecal samples to analyze the microbiome composition and bile acid levels. This investigation aimed to identify any relationships between these factors and the occurrence of PNAC, a condition frequently diagnosed in premature infants receiving parenteral nutrition.
Findings on Gut Microbiome and Bile Acids
The results indicated that cholestatic infants, defined as those developing PNAC, experienced greater exposure to parenteral nutrition and antibiotics compared to non-cholestatic infants. Specifically, cholestatic patients had longer stays in the NICU, with significant p-values of 0.020 for PN exposure, 0.010 for antibiotic exposure, and 0.0038 for NICU duration.
Analysis of the fecal microbiome revealed that non-cholestatic infants had a higher richness of microbial species with a p-value less than 2E-16. In contrast, cholestatic infants exhibited a notable increase in the abundances of Proteobacteria and Fusobacteriota, alongside a decrease in Bacteroidota, also with a high statistical significance (p < 2E-16). Furthermore, the study noted that the genus Akkermansia was present in all infants on low enteral feeds, but its abundance significantly increased in non-cholestatic infants as the volume of feed increased.
Implications for Future Therapeutics
Bile acid analysis showed that cholestatic infants had significantly lower concentrations of deoxycholic acid (p < 2E-16). Additionally, metagenomic analysis indicated an increase in stress responses related to the presence of Proteobacteria in non-cholestatic infants.
This research is the first of its kind to explore the interplay between PNAC susceptibility, microbiome composition, and fecal bile acids in preterm infants. The patterns identified could pave the way for developing targeted therapeutics aimed at this vulnerable population.
The study underscores the importance of understanding the microbiome and bile acid dynamics in managing health outcomes for premature infants reliant on parenteral nutrition. As the field progresses, these findings may lead to innovative treatments that enhance the care of infants facing nutritional challenges.
For more detailed information, the full study can be accessed through the Journal of Clinical and Translational Hepatology, which is published by XIA & HE Publishing Inc. and affiliated with the Second Affiliated Hospital of Chongqing Medical University.
